BiondVax Pharmaceuticals Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/11/2023 | Q2 2023 | -$0.91 | -$1.11 | -0.2 | $0 | |
| 05/15/2023 | Q1 2023 | -$1.19 | $2.02 M | |||
| 04/17/2023 | Q4 2022 | -$0.10 | $0.00 | $0 | ||
| 09/29/2022 | Q3 2022 | $5.24 | $0 | |||
| 08/29/2022 | Q2 2022 | -$6.47 | $0 | |||
| 03/30/2022 | Q1 2022 | -$5.06 | $0 | |||
| 03/28/2022 | Q4 2021 | $0.10 | $20.85 | 20.75 | $2.75 M | |
| 12/27/2021 | Q3 2021 | -$6.31 | $0 | |||
| 06/29/2021 | Q2 2021 | -$8.37 | $0 | |||
| 03/30/2021 | Q1 2021 | -$6.17 | $0 | |||
| 05/13/2021 | Q4 2020 | $0.00 | $0 | |||
| 09/29/2020 | Q3 2020 | $13.92 | $0 | |||
| 06/29/2020 | Q2 2020 | $0.10 | -$38.73 | -38.83 | $0 | |
| 03/30/2020 | Q1 2020 | -$3.62 | $0 | |||
| 06/12/2020 | Q4 2019 | -$0.21 | $0 | |||
| 09/29/2019 | Q3 2019 | -$20.49 | $0 | |||
| 06/29/2019 | Q2 2019 | -$72.49 | $0 | |||
| 03/30/2019 | Q1 2019 | $0.22 | $0 | |||
| 04/30/2019 | Q4 2018 | -$0.34 | $0 | |||
| 09/29/2018 | Q3 2018 | -$3.44 | $0 |
BiondVax Pharmaceuticals Ltd. Earnings: Frequently Asked Questions
-
When is BiondVax Pharmaceuticals Ltd.'s earnings date?
BiondVax Pharmaceuticals Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 29th, 2023 based off last year's report dates.
-
Did BiondVax Pharmaceuticals Ltd. beat their earnings estimates last quarter?
In the previous quarter, BiondVax Pharmaceuticals Ltd. (:BVXV) reported $1.11 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.91 by $2.02.
-
How can I listen to BiondVax Pharmaceuticals Ltd.'s earnings conference call?
The conference call for BiondVax Pharmaceuticals Ltd.'s latest earnings report can be listened to online.
-
How can I read BiondVax Pharmaceuticals Ltd.'s conference call transcript?
The conference call transcript for BiondVax Pharmaceuticals Ltd.'s latest earnings report can be read online.
-
How much profit does BiondVax Pharmaceuticals Ltd. generate each year?
BiondVax Pharmaceuticals Ltd. (:BVXV) has a recorded net income of $0. BiondVax Pharmaceuticals Ltd. has generated $0 earnings per share over the last four quarters.
-
What is BiondVax Pharmaceuticals Ltd.'s price-to-earnings ratio?
BiondVax Pharmaceuticals Ltd. (:BVXV) has a price-to-earnings ratio of -1931344.47 and price/earnings-to-growth ratio is -8719.88.
